dacarbazine has been researched along with Graft vs Host Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilmon, I; Douglas, G; Grigg, A; Minson, A | 1 |
Kagaya, H; Miura, M; Nara, M; Saitoh, H; Sawada, K; Takahashi, N | 1 |
Andreozzi, J; Becker, M; Bernstein, SH; Constine, L; Fisher, RI; Friedberg, JW; Keller, SF; Kelly, JL; Liesveld, J; Oliva, J; Phillips, G; Rich, L; Sensenig, E | 1 |
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N | 1 |
Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N | 1 |
Bonmassar, E; Fioretti, MC; Nardelli, B; Puccetti, P; Romani, L; Sava, G | 1 |
Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Neiman, PE; Sanders, JE; Stewart, P; Storb, R; Sullivan, KM; Thomas, ED | 1 |
1 review(s) available for dacarbazine and Graft vs Host Disease
Article | Year |
---|---|
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines | 2012 |
6 other study(ies) available for dacarbazine and Graft vs Host Disease
Article | Year |
---|---|
Low dose PD-1 inhibition in relapsed refractory Hodgkin lymphoma after allogeneic stem cell transplant with concomitant active GVHD.
Topics: Adult; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Graft vs Host Disease; Hodgkin Disease; Humans; Male; Nivolumab; Programmed Cell Death 1 Receptor; Stem Cell Transplantation; Vinblastine | 2019 |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
Topics: Administration, Oral; Alleles; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Capsules; Combined Modality Therapy; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dacarbazine; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Graft vs Host Disease; Half-Life; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intestines; Itraconazole; Methotrexate; Tacrolimus; Transplantation, Homologous; Vinblastine; Young Adult | 2010 |
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Management; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Vinblastine | 2012 |
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult | 2013 |
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.
Topics: Animals; Antibody Formation; Antigens, Neoplasm; Dacarbazine; Graft Rejection; Graft vs Host Disease; Graft vs Host Reaction; Hypersensitivity, Delayed; Immune Tolerance; Immunosuppressive Agents; Immunotherapy; Lymphocyte Activation; Lymphoma; Mice; Spleen; Structure-Activity Relationship; Triazenes | 1984 |
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Graft vs Host Disease; Herpes Zoster; Hodgkin Disease; Humans; Legionnaires' Disease; Male; Mechlorethamine; Pneumonia, Aspiration; Postoperative Complications; Prednisone; Procarbazine; Time Factors; Transplantation, Homologous; Vinblastine; Vincristine | 1985 |